Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial by Blay, Jean-Yves, Prof, Chevret, Sylvie, Prof, Le Cesne, Axel, Prof, Brahmi, Mehdi, MD, Penel, Nicolas, Prof, Cousin, Sophie, MD, Bertucci, Francois, Prof, Bompas, Emmanuelle, MD, Ryckewaert, Thomas, MD, Soibinet, Pauline, MD, Boudou-Rouquette, Pascaline, MD, Saada Bouzid, Esma, MD, Soulie, Patrick, MD, Valentin, Thibaud, MD, Lotz, Jean-Pierre, Prof, Tosi, Diego, MD, Neviere, Zoé, MD, Cancel, Mathilde, MD, Ray-Coquard, Isabelle, Prof, Gambotti, Laetitia, MD, Legrand, Frédéric, PhD, Lamrani-Ghaouti, Assia, PhD, Simon, Clotilde, PhD, Even, Caroline, MD, Massard, Christophe, Prof

Get full text

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study by Witkowski, Benoit, PhD, Duru, Valentine, MSc, Khim, Nimol, PhD, Ross, Leila S, PhD, Saintpierre, Benjamin, MSc, Beghain, Johann, MSc, Chy, Sophy, BS, Kim, Saorin, BS, Ke, Sopheakvatey, BS, Kloeung, Nimol, BS, Eam, Rotha, BS, Khean, Chanra, BS, Ken, Malen, BS, Loch, Kaknika, BS, Bouillon, Anthony, PhD, Domergue, Anais, MSc, Ma, Laurence, MSc, Bouchier, Christiane, PhD, Leang, Rithea, PhD, Huy, Rekol, MD, Nuel, Grégory, Prof, Barale, Jean-Christophe, PhD, Legrand, Eric, PhD, Ringwald, Pascal, MD, Fidock, David A, Prof, Mercereau-Puijalon, Odile, PhD, Ariey, Frédéric, PhD, Ménard, Didier, Dr

Get full text